Embed this press release by copying the code below:
NASDAQ: RLMD Investor Notice: Investigation over Possible Wrongdoing at Relmada Therapeutics, Inc.
NASDAQ: RLMD Investor Notice: Investigation over Possible Wrongdoing at Relmada Therapeutics, Inc.